VAERS reports by lot

GSK Varicella/Shingles lot EG3A3: VAERS reports

21 VAERS reports list lot EG3A3 as a GSK Varicella/Shingles vaccine, received between 2020-05-28 and 2021-07-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
14%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1724%
Injection-site / Local reaction1724%
Dermatological (non-injection-site)1014%
Neurological811%
Musculoskeletal710%
Allergic / Anaphylactic57%
Gastrointestinal34%
Cardiac / Cardiovascular23%
Respiratory23%

Where reports came from

U.S. state of the reporter, where given (top 12).

Ohio3
Wisconsin2
Illinois2
Washington2
Kentucky1
Iowa1
New York1
Wyoming1
Georgia1
Michigan1
Pennsylvania1
Nevada1

Reports by month received

2020-051
2020-064
2020-072
2020-081
2020-093
2020-103
2020-112
2020-121
2021-031
2021-041
2021-061
2021-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.